Reports and Findings
Research
Working Towards a Better Understanding of ARFJonathan Michael Tobias Carapetis AM Serralha Kollmann AM MBBS FRACP FAFPHM PhD FAHMS PhD, M.D., SFUW Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Research Assistant Honorary Research Associate 08 6319 1000 08 6319 1050
Research
What risk does underlying trimethoprim resistance pose for the development of cotrimoxazole-resistant skin infectionsTim Barnett PhD Head, Strep A Pathogenesis and Diagnostics timothy.barnett@thekids.org.au Head, Strep A Pathogenesis and Diagnostics Tim has worked on disease-causing mechanisms of Streptococcus pyogenes (Group A Streptococcus, Strep A) since his
Research
Tonsil organ model to evaluate carriage, disease mechanisms and therapeutic interventions for treatment and prevention of GAS infectionsTim Barnett PhD Head, Strep A Pathogenesis and Diagnostics timothy.barnett@thekids.org.au Head, Strep A Pathogenesis and Diagnostics Tim has worked on disease-causing mechanisms of Streptococcus pyogenes (Group A Streptococcus, Strep A) since his
Research
Penicillin Levels for Rheumatic Heart Disease Study – Remote CohortAsha Jonathan Bowen Carapetis AM BA MBBS DCH FRACP PhD GAICD FAHMS OAM AM MBBS FRACP FAFPHM PhD FAHMS Head, Healthy Skin and ARF Prevention Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au
Research
The NZ BPG Pharmacokinetics StudyJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is
Research
The END RHD CRE: Developing an end game for rheumatic heart disease in AustraliaJonathan Glenn Katharine Rosemary Tom Carapetis AM Pearson Noonan Wyber Snelling AM MBBS FRACP FAFPHM PhD FAHMS BA (Education) PhD Candidate MBBS (Hons) MSc MBChB MPH FRACGP PhD BMBS DTMH GDipClinEpid PhD FRACP Executive Director; Co-Head, Strep A
Research
Australian Strep A Vaccine Initiative (ASAVI)The Australian Strep A Vaccine Initiative (ASAVI) is an Australian-led global initiative with the goal of reducing the disease burden caused by Group A Streptococcus (Strep A) infection through effective vaccination.
Research
Skin health situational analysis to inform skin disease control programs for the KimberleyMarianne John Rebecca Stephanie Asha Jonathan Mullane Jacky Pavlos Enkel Bowen Carapetis AM BSc (OT) PhD, MSFS BSc (Hons), MPH, MIPH BA MBBS DCH FRACP PhD GAICD FAHMS OAM AM MBBS FRACP FAFPHM PhD FAHMS Program Advisor, SToP Trial Community
Research
Skin Health Situational Analysis to inform skin disease control programs for the Kimberley - outcomesThe Skin Health Situational Analysis was conducted in 2017 with and for stakeholders in the Kimberley region as a precursor to the SToP Trial to highlight all that was already known prior to commencement in 2018. It was completed to be a resource for communities in the Kimberley who would like to de
Research
Skin Care Assessment in Broome and Port Hedland (SCAB Heal) projectAsha Bowen BA MBBS DCH FRACP PhD GAICD FAHMS OAM Head, Healthy Skin and ARF Prevention Head, Healthy Skin and ARF Prevention Areas of expertise: Skin infections, clinical trials, Streptococcus pyogenes, Staphylococcus aureus, Aboriginal children,